TENS-Integrated Transdermal Patch for Analgesic Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pain relief methods, such as TENS and transdermal patches, are limited in their ability to effectively deliver analgesics and increase blood circulation for enhanced pain management, particularly for chronic and musculoskeletal pain.
Innovation Solution
An electrically stimulated CBD infused anesthetic patch system that combines a transdermal patch with electrodes and a TENS device to deliver a controlled electric current, increasing blood circulation and maximizing the absorption of analgesics like Menthol, CBD, Lidocaine, or Capsaicin through the skin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a transdermal patch is used to deliver analgesics, then the medication can be delivered through the skin, but the absorption rate is limited and blood circulation is not sufficiently increased
Solution Approach 1:
The patent combines a transdermal patch with TENS (transcutaneous electrical nerve stimulation) technology into a single integrated device. The patch contains both the analgesic medication reservoir and electrodes for electrical stimulation, allowing simultaneous drug delivery and blood flow enhancement through one application rather than requiring separate devices
Solution Approach 2:
The transdermal patch is designed to perform multiple functions: it delivers analgesic medication through the skin while simultaneously using electrical stimulation to increase blood circulation and enhance absorption. This multi-functional approach eliminates the need for separate devices for drug delivery and circulation enhancement
2Productivity
If electrical stimulation is applied to increase blood circulation, then analgesic absorption is enhanced, but the device complexity increases
Solution Approach 1:
The patent integrates the electrical stimulation components directly into the transdermal patch structure. The electrodes are embedded within the patch layers, and the medication reservoir is positioned to work in conjunction with the stimulation areas, creating a unified device that delivers both functions through a single application
3Reliability
If higher doses of analgesics are used to improve pain relief, then pain management effectiveness increases, but the risk of side effects and toxicity increases
Solution Approach 1:
The patent utilizes electrical stimulation parameters (current intensity, frequency, pulse duration) to enhance the bioavailability and effectiveness of lower doses of analgesics. By optimizing these electrical parameters, the system achieves improved pain relief with reduced medication quantities, thereby minimizing side effects and toxicity risks
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively relieves pain by maximizing the release of analgesics, treating pain, and increasing blood flow in treated areas, providing relief for conditions like arthritis.
Implementation Method 1
Transcutaneous electrical nerve stimulation (TENS) is an inexpensive nonpharmacological intervention used in the treatment of acute and chronic pain conditions. These small battery-powered devices deliver alternating current via cutaneous electrodes positioned near the painful area.
Implementation Method 2
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Data Source
AI summary
An electrically stimulated CBD infused anesthetic patch system that is placed on a human's skin that is used to relieve pain. The electrically stimulated CBD infused anesthetic patch system comprises of a transdermal patch that has electrodes that receive an electric current from a TENS device. The transdermal patch is impregnated with a solution that has at least one analgesic that is selected from the group consisting of Menthol, CBD, Lidocaine or Capsaicin. The solution shall also include inactive ingredients.